Swiss National Bank’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-104,700
| Closed | -$428K | – | 2486 |
|
|
2024
Q2 | $428K | Buy |
104,700
+7,300
| +7% | +$29.9K | ﹤0.01% | 2433 |
|
|
2024
Q1 | $1.54M | Hold |
97,400
| – | – | ﹤0.01% | 1985 |
|
|
2023
Q4 | $1.48M | Sell |
97,400
-11,000
| -10% | -$167K | ﹤0.01% | 2014 |
|
|
2023
Q3 | $2.17M | Sell |
108,400
-14,200
| -12% | -$285K | ﹤0.01% | 1788 |
|
|
2023
Q2 | $3.46M | Buy |
122,600
+24,100
| +24% | +$680K | ﹤0.01% | 1532 |
|
|
2023
Q1 | $1.69M | Sell |
98,500
-11,500
| -10% | -$198K | ﹤0.01% | 1943 |
|
|
2022
Q4 | $2.22M | Buy |
110,000
+2,000
| +2% | +$40.3K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $2.34M | Hold |
108,000
| – | – | ﹤0.01% | 1758 |
|
|
2022
Q2 | $3.04M | Buy |
108,000
+54,400
| +101% | +$1.53M | ﹤0.01% | 1634 |
|
|
2022
Q1 | $2.47M | Buy |
53,600
+4,000
| +8% | +$185K | ﹤0.01% | 1913 |
|
|
2021
Q4 | $4.17M | Buy |
49,600
+4,000
| +9% | +$336K | ﹤0.01% | 1577 |
|
|
2021
Q3 | $3.04M | Buy |
45,600
+800
| +2% | +$53.3K | ﹤0.01% | 1777 |
|
|
2021
Q2 | $2.38M | Buy |
44,800
+3,000
| +7% | +$160K | ﹤0.01% | 1987 |
|
|
2021
Q1 | $1.81M | Buy |
41,800
+1,100
| +3% | +$47.7K | ﹤0.01% | 2062 |
|
|
2020
Q4 | $2.11M | Buy |
+40,700
| New | +$2.11M | ﹤0.01% | 1872 |
|